105 related articles for article (PubMed ID: 8185566)
1. Apolipoprotein E and cholesterol affect neuronal calcium signalling: the possible relationship to beta-amyloid neurotoxicity.
Hartmann H; Eckert A; Müller WE
Biochem Biophys Res Commun; 1994 May; 200(3):1185-92. PubMed ID: 8185566
[TBL] [Abstract][Full Text] [Related]
2. Lymphocytes and neutrophils as peripheral models to study the effect of beta-amyloid on cellular calcium signalling in Alzheimer's disease.
Eckert A; Förstl H; Zerfass R; Hartmann H; Müller WE
Life Sci; 1996; 59(5-6):499-510. PubMed ID: 8761338
[TBL] [Abstract][Full Text] [Related]
3. Effects of beta-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of A beta 1-42 and A beta 1-43.
Müller WE; Eckert GP; Scheuer K; Cairns NJ; Maras A; Gattaz WF
Amyloid; 1998 Mar; 5(1):10-5. PubMed ID: 9547000
[TBL] [Abstract][Full Text] [Related]
4. beta-Amyloid peptide decreases membrane fluidity.
Müller WE; Koch S; Eckert A; Hartmann H; Scheuer K
Brain Res; 1995 Mar; 674(1):133-6. PubMed ID: 7773681
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E and beta A4-amyloid: signals and effects.
Ohm TG; Hamker U; Cedazo-Minguez A; Röckl W; Scharnagl H; März W; Cowburn R; Müller W; Meske V
Biochem Soc Symp; 2001; (67):121-9. PubMed ID: 11447828
[TBL] [Abstract][Full Text] [Related]
6. Intracellular calcium changes in neuronal cells induced by Alzheimer's beta-amyloid protein are blocked by estradiol and cholesterol.
Kawahara M; Kuroda Y
Cell Mol Neurobiol; 2001 Feb; 21(1):1-13. PubMed ID: 11440193
[TBL] [Abstract][Full Text] [Related]
7. beta-Amyloid protein amplifies calcium signalling in central neurons from the adult mouse.
Hartmann H; Eckert A; Müller WE
Biochem Biophys Res Commun; 1993 Aug; 194(3):1216-20. PubMed ID: 8352778
[TBL] [Abstract][Full Text] [Related]
8. Aniracetam restores the effects of amyloid-beta protein or ageing on membrane fluidity and intracellular calcium concentration in mice synaptosomes.
Li Y; Wang JJ; Cai JX
J Neural Transm (Vienna); 2007; 114(11):1407-11. PubMed ID: 17557127
[TBL] [Abstract][Full Text] [Related]
9. The amplifying effect of beta-amyloid on cellular calcium signalling is reduced in Alzheimer's disease.
Eckert A; Förstl H; Hartmann H; Czech C; Mönning U; Beyreuther K; Müller WE
Neuroreport; 1995 May; 6(8):1199-202. PubMed ID: 7662907
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs.
Kumar R; Nordberg A; Darreh-Shori T
Brain; 2016 Jan; 139(Pt 1):174-92. PubMed ID: 26525916
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E.
Whitson JS; Mims MP; Strittmatter WJ; Yamaki T; Morrisett JD; Appel SH
Biochem Biophys Res Commun; 1994 Feb; 199(1):163-70. PubMed ID: 8123007
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease.
Hirsch-Reinshagen V; Wellington CL
Curr Opin Lipidol; 2007 Jun; 18(3):325-32. PubMed ID: 17495608
[TBL] [Abstract][Full Text] [Related]
13. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.
Castano EM; Prelli F; Wisniewski T; Golabek A; Kumar RA; Soto C; Frangione B
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):599-604. PubMed ID: 7534068
[TBL] [Abstract][Full Text] [Related]
14. Quercetin stabilizes apolipoprotein E and reduces brain Aβ levels in amyloid model mice.
Zhang X; Hu J; Zhong L; Wang N; Yang L; Liu CC; Li H; Wang X; Zhou Y; Zhang Y; Xu H; Bu G; Zhuang J
Neuropharmacology; 2016 Sep; 108():179-92. PubMed ID: 27114256
[TBL] [Abstract][Full Text] [Related]
15. ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Aβ production independently of their cholesterol efflux capacity.
Dafnis I; Raftopoulou C; Mountaki C; Megalou E; Zannis VI; Chroni A
Biochem J; 2018 May; 475(10):1839-1859. PubMed ID: 29743204
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol attenuates the membrane perturbing properties of beta-amyloid peptides.
Kirsch C; Eckert GP; Mueller WE
Amyloid; 2002 Sep; 9(3):149-59. PubMed ID: 12408677
[TBL] [Abstract][Full Text] [Related]
17. Neurite degeneration elicited by apolipoprotein E peptides.
Crutcher KA; Clay MA; Scott SA; Tian X; Tolar M; Harmony JA
Exp Neurol; 1994 Nov; 130(1):120-6. PubMed ID: 7821387
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease.
Eckert GP; Cairns NJ; Maras A; Gattaz WF; Müller WE
Dement Geriatr Cogn Disord; 2000; 11(4):181-6. PubMed ID: 10867442
[TBL] [Abstract][Full Text] [Related]
19. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.
Fitz NF; Tapias V; Cronican AA; Castranio EL; Saleem M; Carter AY; Lefterova M; Lefterov I; Koldamova R
Brain; 2015 Dec; 138(Pt 12):3699-715. PubMed ID: 26510953
[TBL] [Abstract][Full Text] [Related]
20. Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of amyloid-beta peptide.
Sponne I; Fifre A; Koziel V; Oster T; Olivier JL; Pillot T
FASEB J; 2004 May; 18(7):836-8. PubMed ID: 15001562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
